VERACYTE INC (VCYT) Stock Fundamental Analysis
USA - NASDAQ:VCYT - US92337F1075 - Common Stock
36.08 USD
+0.75 (+2.12%)
36.19 USD
+0.11 (+0.3%)
Overall VCYT gets a fundamental rating of 6 out of 10. We evaluated VCYT against 534 industry peers in the Biotechnology industry. VCYT has an excellent financial health rating, but there are some minor concerns on its profitability. VCYT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes VCYT very considerable for growth investing!
1. Profitability
1.1 Basic Checks
VCYT had positive earnings in the past year.
In the past year VCYT had a positive cash flow from operations.
In the past 5 years VCYT reported 4 times negative net income.
In multiple years VCYT reported negative operating cash flow during the last 5 years.
1.2 Ratios
VCYT has a Return On Assets of 1.96%. This is amongst the best in the industry. VCYT outperforms 90.26% of its industry peers.
With an excellent Return On Equity value of 2.16%, VCYT belongs to the best of the industry, outperforming 91.20% of the companies in the same industry.
VCYT has a Return On Invested Capital of 2.32%. This is amongst the best in the industry. VCYT outperforms 90.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.96% | ||
| ROE | 2.16% | ||
| ROIC | 2.32% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
VCYT has a better Profit Margin (5.50%) than 91.20% of its industry peers.
VCYT has a better Operating Margin (7.78%) than 91.39% of its industry peers.
VCYT has a Gross Margin of 68.26%. This is amongst the best in the industry. VCYT outperforms 80.90% of its industry peers.
In the last couple of years the Gross Margin of VCYT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.78% | ||
| PM (TTM) | 5.5% | ||
| GM | 68.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
VCYT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, VCYT has more shares outstanding
Compared to 5 years ago, VCYT has more shares outstanding
There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
VCYT has an Altman-Z score of 13.85. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of VCYT (13.85) is better than 85.96% of its industry peers.
There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 13.85 |
ROIC/WACC0.27
WACC8.75%
2.3 Liquidity
VCYT has a Current Ratio of 5.43. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
VCYT's Current ratio of 5.43 is in line compared to the rest of the industry. VCYT outperforms 59.36% of its industry peers.
VCYT has a Quick Ratio of 5.10. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
VCYT has a Quick ratio (5.10) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.43 | ||
| Quick Ratio | 5.1 |
3. Growth
3.1 Past
VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 144.00%, which is quite impressive.
VCYT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.91%.
VCYT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.93% yearly.
EPS 1Y (TTM)144%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.29%
Revenue 1Y (TTM)19.91%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.75%
3.2 Future
VCYT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.73% yearly.
Based on estimates for the next years, VCYT will show a quite strong growth in Revenue. The Revenue will grow by 10.07% on average per year.
EPS Next Y25.8%
EPS Next 2Y66.16%
EPS Next 3Y59.49%
EPS Next 5Y51.73%
Revenue Next Year12.84%
Revenue Next 2Y11.31%
Revenue Next 3Y10.68%
Revenue Next 5Y10.07%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 109.33, which means the current valuation is very expensive for VCYT.
Based on the Price/Earnings ratio, VCYT is valued cheaply inside the industry as 90.64% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.10, VCYT is valued quite expensively.
The Price/Forward Earnings ratio is 43.56, which means the current valuation is very expensive for VCYT.
Based on the Price/Forward Earnings ratio, VCYT is valued cheaply inside the industry as 90.07% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.52. VCYT is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 109.33 | ||
| Fwd PE | 43.56 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.57% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, VCYT is valued cheaper than 93.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.8 | ||
| EV/EBITDA | 39.13 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of VCYT may justify a higher PE ratio.
A more expensive valuation may be justified as VCYT's earnings are expected to grow with 59.49% in the coming years.
PEG (NY)4.24
PEG (5Y)N/A
EPS Next 2Y66.16%
EPS Next 3Y59.49%
5. Dividend
5.1 Amount
VCYT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
36.08
+0.75 (+2.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners109.55%
Inst Owner Change-0.72%
Ins Owners0.56%
Ins Owner Change-0.42%
Market Cap2.84B
Revenue(TTM)479.13M
Net Income(TTM)26.34M
Analysts83.53
Price Target42.05 (16.55%)
Short Float %8.59%
Short Ratio7.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.08%
Min EPS beat(2)-110.32%
Max EPS beat(2)72.17%
EPS beat(4)2
Avg EPS beat(4)123.1%
Min EPS beat(4)-110.32%
Max EPS beat(4)579.09%
EPS beat(8)4
Avg EPS beat(8)77.32%
EPS beat(12)8
Avg EPS beat(12)65.1%
EPS beat(16)11
Avg EPS beat(16)51.9%
Revenue beat(2)2
Avg Revenue beat(2)3.39%
Min Revenue beat(2)1.01%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.66%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.2%
Revenue beat(12)11
Avg Revenue beat(12)5.28%
Revenue beat(16)15
Avg Revenue beat(16)5.66%
PT rev (1m)0%
PT rev (3m)-1.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.15%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.21%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)1.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 109.33 | ||
| Fwd PE | 43.56 | ||
| P/S | 5.92 | ||
| P/FCF | 33.8 | ||
| P/OCF | 30.37 | ||
| P/B | 2.32 | ||
| P/tB | 8.06 | ||
| EV/EBITDA | 39.13 |
EPS(TTM)0.33
EY0.91%
EPS(NY)0.83
Fwd EY2.3%
FCF(TTM)1.07
FCFY2.96%
OCF(TTM)1.19
OCFY3.29%
SpS6.09
BVpS15.52
TBVpS4.47
PEG (NY)4.24
PEG (5Y)N/A
Graham Number10.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.96% | ||
| ROE | 2.16% | ||
| ROCE | 2.94% | ||
| ROIC | 2.32% | ||
| ROICexc | 3.11% | ||
| ROICexgc | 37.8% | ||
| OM | 7.78% | ||
| PM (TTM) | 5.5% | ||
| GM | 68.26% | ||
| FCFM | 17.52% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score7
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 41.28% | ||
| Cap/Sales | 1.98% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 155.1% | ||
| Profit Quality | 318.84% | ||
| Current Ratio | 5.43 | ||
| Quick Ratio | 5.1 | ||
| Altman-Z | 13.85 |
F-Score7
WACC8.75%
ROIC/WACC0.27
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)144%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.29%
EPS Next Y25.8%
EPS Next 2Y66.16%
EPS Next 3Y59.49%
EPS Next 5Y51.73%
Revenue 1Y (TTM)19.91%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.75%
Revenue Next Year12.84%
Revenue Next 2Y11.31%
Revenue Next 3Y10.68%
Revenue Next 5Y10.07%
EBIT growth 1Y52395.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year275.46%
EBIT Next 3Y68.01%
EBIT Next 5Y44.31%
FCF growth 1Y264.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y198.77%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status for VCYT stock?
ChartMill assigns a valuation rating of 5 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
How financially healthy is VERACYTE INC?
The financial health rating of VERACYTE INC (VCYT) is 7 / 10.
What is the expected EPS growth for VERACYTE INC (VCYT) stock?
The Earnings per Share (EPS) of VERACYTE INC (VCYT) is expected to grow by 25.8% in the next year.